Tirzepatide
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
Eli Lilly · Phase 3 · Completed · Enrollment 731
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Tirzepatide | Obesity or overweight | n/r | 4 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 4 | n/r | n/r |